Syremis Therapeutics Appoints Dr. Aaron Koenig as Chief Medical Officer
PRIVATEJun 16, 2026
Position
Chief Medical Officer
Company
Syremis Therapeutics
Aaron Koenig
Tel AvivBiotechnologyHealth Care
Description
Syremis Therapeutics, a clinical-stage biopharmaceutical company, announced the appointment of Aaron Koenig, MD, as Chief Medical Officer. Dr. Koenig brings extensive experience in neuropsychiatric drug development to the executive team.
Who to call at Syremis Therapeutics, and when
A new leader at Syremis Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Syremis Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Syremis Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Syremis Therapeutics
Location
Tel Aviv, Tel Aviv District, Israel
About
Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company’s neuropsychiatric pipeline is rooted in emerging and clinically validated mechanisms, including muscarinic M1/M4 agonism and next-generation NMDA antagonism.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Syremis Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Tel AvivBiotechnologyHealth Care